Why Most Patients in Japan Are Missing Out on New Alzheimer’s Treatments

A recent study has revealed a significant gap between interest and access when it comes to new treatments for Alzheimer’s disease in Japan. Despite growing awareness and curiosity about the latest medications, fewer than one in five patients who expressed interest actually went on to receive them. Researchers found that several barriers stand in the… Continue reading Why Most Patients in Japan Are Missing Out on New Alzheimer’s Treatments

Alzheimer’s Drug Research Takes Cues From Cancer’s Multi-Target Strategy

Efforts to develop effective treatments for Alzheimer’s disease are increasingly moving away from a single-target approach and toward a more complex strategy inspired by advances in cancer therapy. Recent clinical trials — including those that did not achieve their intended outcomes — are reinforcing the idea that Alzheimer’s is driven by multiple biological pathways rather… Continue reading Alzheimer’s Drug Research Takes Cues From Cancer’s Multi-Target Strategy